Review
The incoming AR reviews your documentation before accepting the mandate in writing.
Your EU Authorised Representative & PRRC for MDR/IVDR medical devices
Manufacturers can change their EU Authorised Representative, but Article 12 of the MDR and IVDR requires the switch to be defined in an agreement so that there is never a gap in representation or in vigilance reporting.
The detailed arrangements are set out in an agreement between the manufacturer, where practicable the outgoing Authorised Representative, and the incoming Authorised Representative. It must address at least:
The incoming AR reviews your documentation before accepting the mandate in writing.
Sign the Article 12 agreement with fixed dates for the handover.
Update EUDAMED actor data and inform your Notified Body where one is involved.
Switch labels and instructions to the new AR by the agreed date; plan for stock already on the market.
Article 12 requires the outgoing Authorised Representative to be party to the agreement only "where practicable". If the relationship has broken down, the manufacturer and incoming AR still document the arrangements, and the manufacturer should keep evidence of the notice of termination and of its attempts to obtain the documents.
Yes, subject to the terms of your mandate. Article 12 MDR/IVDR requires the change to be defined in an agreement covering the handover dates, labelling transition, document transfer and forwarding of incident reports.
The agreement sets the date until which the outgoing Authorised Representative may still be indicated in the information you supply. Devices already placed on the market before the change are not relabelled by default.
Where a Notified Body is involved, inform it of the change of Authorised Representative as required by your certification agreement.
What a new mandate must cover.
Updating labels after a change.
Updating your actor data.
Note: This guide provides general information about Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR), not legal advice. Specific obligations depend on your device and company structure. Last reviewed 30 September 2026.
Tell us your device type, class and where your company is established. We will qualify the next step before any mandate is signed.